Treatment Resistance Specialist

Treatment-Resistant Depression in STMA:
Hope When Medications Fail.

Have 2 or more antidepressants failed to relieve your depression? You are not out of options. Experience proven NeuroStar® TMS therapy just 10 minutes west on I-94.

Home / Locations / STMA / Treatment-Resistant Depression
When Pills Stop Working

Why Do Antidepressants Stop Working for STMA Patients?

In landmark psychiatric research (the STAR*D study), clinical trials proved that if a patient does not achieve remission from their first two medication trials, the likelihood of success with a third or fourth pill drops below 15%. Yet millions of Americans are kept on an endless cycle of dose increases and drug combinations.

Treatment-Resistant Depression (TRD) is a physiological issue, not a personal weakness. When neural circuits in the left dorsolateral prefrontal cortex become chronically understimulated, chemicals cannot reach the receptors effectively. NeuroStar® TMS therapy physically wakes up these dormant circuits through focused magnetic stimulation, helping over 80% of treatment-resistant patients experience measurable relief.

The NeuroStar Advantage for TRD:
• Proven After Medication Failure: Designed specifically for treatment resistance
• Up to 62% Full Remission: Complete liberation from depression symptoms
• Easy 10-Min Commute: Quick reverse commute west on I-94
• Covered by Most Insurance: In-network TRD coverage in MN

Common Medications Our Patients Have Tried:

Most STMA patients who achieve remission with TMS have previously taken one or more of these medications:

Sertraline (Zoloft)
Escitalopram (Lexapro)
Fluoxetine (Prozac)
Venlafaxine (Effexor)
Duloxetine (Cymbalta)
Bupropion (Wellbutrin)
If you have tried 2 or more of these without relief, you likely meet standard insurance criteria for full TMS coverage!
Clinical Breakthrough

Why TMS Succeeds Where Medications Fail

The science of focused neurostimulation over whole-body chemical saturation:

Targeted Brain Circuitry

Rather than relying on chemical absorption through digestion and bloodstream, TMS creates focused magnetic fields that depolarize neurons directly in the dorsolateral prefrontal cortex.

How TMS Works →

Objective Cognitive Tracking

Throughout your TRD care plan, we utilize computerized Creyos cognitive assessments to measure tangible improvements in attention, memory, and executive function.

Cognitive Testing Details →
Nearby Surrounding Communities

Serving Wright, Hennepin, and Sherburne counties with advanced TRD care:

Common Questions

Frequently Asked Questions: Treatment-Resistant Depression in STMA

Clear clinical answers for St. Michael and Albertville residents considering TMS for TRD.

Treatment-Resistant Depression (TRD) is clinically diagnosed when a patient diagnosed with Major Depressive Disorder does not achieve adequate remission after completing two or more antidepressant medication trials at therapeutic dosages and durations. Read more about TRD criteria.
The landmark STAR*D clinical trial demonstrated that after two failed medications, the chance of reaching remission with a third or fourth drug drops to under 15%. This occurs because systemic medications cannot resolve localized neurological hypoactivity in the prefrontal cortex.
NeuroStar delivers focused, MRI-strength magnetic pulses directly to the underactive left dorsolateral prefrontal cortex. This stimulates neuron firing, releases brain-derived neurotrophic factor (BDNF), and rebuilds synaptic connections through neuroplasticity. Learn more in What Is TMS Therapy.
In extensive real-world clinical registry studies of over 14,000 patients, 83% of individuals completing NeuroStar therapy experienced a significant reduction in depressive symptoms, and 62% achieved complete clinical remission. Explore our NeuroStar TMS page.
The drive takes only 10 minutes (9 to 11 miles) heading westbound on I-94 to Monticello Exit 193/194. Sessions take only 19 minutes with zero downtime, allowing you to drive directly to work or home. See our STMA Location Guide.
Yes. Blue Cross Blue Shield of Minnesota, HealthPartners, Medica, UnitedHealthcare, Medicare, Optum, Cigna, and Aetna all have established clinical coverage policies for FDA-cleared TMS therapy for treatment-resistant depression. Check our Insurance Guide.
You can request a complimentary 15-minute consultation through our Contact page or call 612-429-8280. Our clinical team coordinates medical records and submits insurance pre-authorization directly on your behalf.
Your Next Step

Your Path Forward
Starts Here

Schedule your free 15-minute consultation to learn more about your treatment options. During this no-obligation consultation, we'll:

  • Listen to your unique experience
  • Explain how Neurostar® TMS might help your specific condition
  • Answer all your questions about treatment
  • Discuss practical matters like insurance and scheduling